Metastatic Retinoblastoma

1

Review clinical trials related to Metastatic Retinoblastoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

This is a first in human dose escalation trial to determine the safety of administering GPC2 CAR T cells in patients with advanced neuroblastoma or retinoblastoma.

Participants needed: 45
Trial details
Phase: Phase 1Age: 1+Biological sex: AllType: InterventionalSponsor: Stephan Grupp MD PhDUpdated: Dec 29, 2025Locations: 1
Eligibility criteria

Patients must be ≥ 1 year of age [+12]

Patients with active hepatitis B or active hepatitis C. [+35]